Biomet settles a portion of a patent infringement lawsuit brought by an affiliate of patent troll Acacia Research Group and loses a European case brought over some of its bone cements.
Biomet said this week that it settled a portion of a patent infringement case with a notorious patent troll and lost a trade secrets theft lawsuit brought in Germany over some of its bone cements.
Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific prevails in 1st pelvic mesh trial; Bard settles more than 500 pelvic mesh complaints; Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year; Ex-sales rep's counter-claims stand in poaching spat with Stryker; ResMed kicks Apex sleep masks out of Germany
Counter-claims by an ex-Stryker sales rep can stand in a poaching dispute involving Biomet, a federal judge rules.
Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger
A Michigan federal judge denies a settlement in the poaching spat between Biomet and Stryker and a pair of ex-Stryker sales reps.
Here's a look at some of the top legal news stories for medical device companies this week: Guidant can't slip breach-of-contract charges in Johnson & Johnson suit; Biomet reveals SEC subpoena over alleged 'improprieties' in Brazil, Mexico; Appeals court upholds Retractable Technologies win over Becton Dickinson; Board suspends ex-PricewaterhouseCoopers accountant over ArthroCare scandal; Covidien's Nellcor and CAS Medical settle dispute for $275k
, Becton Dickinson & Co.
, Boston Scientific
, CAS Medical Systems Inc.
, Dept. of Justice (DOJ)
, Guidant Corp.
, Johnson & Johnson
, Public Company Accounting Oversight Board
, Retractable Technologies Inc.
, Securities & Exchange Commission (SEC)
, Abbott Laboratories
Biomet puts black ink back in the ledger for its fiscal 4th quarter and 2014, reporting double-digit adjusted profit increases for both periods.
Biomet said yesterday that it put black ink back into its books for the fiscal 4th quarter and 2014, with adjusted profits rising by double digits.